8 stimulation,” Anatomical Record Part A, vol. 284, no. 1, pp. 460–465, 2005. [21] Y. Carrasquillo and R. W. Gereau IV, “Activation of the extra- cellular signal-regulated kinase in the amygdala modulates pain perception,” Journal of Neuroscience, vol. 27, no. 7, pp. 1543–1551, 2007. [22] H. Cao, Y.-J. Gao, W.-H. Ren et al., “Activation of extracel- lular signal-regulated kinase in the anterior cingulate cortex contributes to the induction and expression of aﬀective pain,” Journal of Neuroscience, vol. 29, no. 10, pp. 3307–3321, 2009. [23] F. Wei and M. Zhuo, “Activation of Erk in the anterior cingulate cortex during the induction and expression of chronic pain,” Molecular Pain, vol. 4, article 28, 2008. [24] Y.-J. Seo, M.-S. Kwon, S.-S. Choi et al., “Characterization of the hypothalamic proopiomelanocortin gene and β-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inﬂammatory pain,” Neuroscience, vol. 152, no. 4, pp. 1054–1066, 2008. [25] S.-S. Choi, Y.-J. Seo, M.-S. Kwon et al., “Involvement of phosphorylated extracellular signal-regulated kinase in the mouse substance P pain model,” Molecular Brain Research, vol. 137, no. 1-2, pp. 152–158, 2005. [26] S.-S. Choi, Y.-J. Seo, E.-J. Shim et al., “Involvement of phosphorylated Ca2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model,” Brain Research, vol. 1108, no. 1, pp. 28–38, 2006. [27] R.-R. Ji, T. Kohno, K. A. Moore, and C. J. Woolf, “Central sensitization and LTP: do pain and memory share similar mechanisms?” Trends in Neurosciences, vol. 26, no. 12, pp. 696– 705, 2003. [28] J. M. English and M. H. Cobb, “Pharmacological inhibitors of MAPK pathways,” Trends in Pharmacological Sciences, vol. 23, no. 1, pp. 40–45, 2002. [29] H. Imbe, A. Kimura, K. Okamoto et al., “Activation of ERK in the rostral ventromedial medulla is involved in hyperalgesia during peripheral inﬂammation,” Brain Research, vol. 1187, no. 1, pp. 103–110, 2008. [30] D. Julius and A. I. Basbaum, “Molecular mechanisms of nociception,” Nature, vol. 413, no. 6852, pp. 203–210, 2001. [31] H. Imbe, Y. Iwai-Liao, and E. Senba, “Stress-induced hyperal- gesia: animal models and putative mechanisms,” Frontiers in Bioscience, vol. 11, no. 1, pp. 2179–2192, 2006. [32] P. B. Wood, “Stress and dopamine: implications for the patho- physiology of chronic widespread pain,” Medical Hypotheses, vol. 62, no. 3, pp. 420–424, 2004. [33] M. M. Delvaux, “Stress and visceral perception,” Canadian Journal of Gastroenterology, vol. 13, pp. 32A–36A, 1999. [34] M. Herrmann, J. Scholmerich, and R. H. Straub, “Stress and rheumatic diseases,” Rheumatic Disease Clinics of North America, vol. 26, no. 4, pp. 737–763, 2000. [35] J. M. Nash and R. W. Thebarge, “Understanding psycholog- ical stress, its biological processes, and impact on primary headache,” Headache, vol. 46, no. 9, pp. 1377–1386, 2006. [36] H. P. Rome Jr. and J. D. Rome, “Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of aﬀective and sensory symptoms in chronic pain disorders,” Pain Medicine, vol. 1, no. 1, pp. 7–23, 2000. [37] Y. Kawasaki, T. Kohno, Z.-Y. Zhuang et al., “Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-ﬁber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization,” Journal of Neuroscience, vol. 24, no. 38, pp. 8310–8321, 2004. Journal of Signal Transduction [38] J. L. Wood and A. F. Russo, “Autoregulation of cell-speciﬁc MAP kinase control of the tryptophan hydroxylase promoter,” Journal of Biological Chemistry, vol. 276, no. 24, pp. 21262– 21271, 2001. [39] T. Oyama, M. Ueda, Y. Kuraishi, A. Akaike, and M. Satoh, “Dual eﬀect of serotonin on formalin-induced nociception in the rat spinal cord,” Neuroscience Research, vol. 25, no. 2, pp. 129–135, 1996. [40] M. Morales and S.-D. Wang, “Diﬀerential composition of 5- hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system,” Journal of Neuroscience, vol. 22, no. 15, pp. 6732–6741, 2002. [41] R. Suzuki, L. J. Rygh, and A. H. Dickenson, “Bad news from the brain: descending 5-HT pathways that control spinal pain processing,” Trends in Pharmacological Sciences, vol. 25, no. 12, pp. 613–617, 2004. [42] F. Wei, R. Dubner, S. Zou et al., “Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain,” Journal of Neuroscience, vol. 30, no. 25, pp. 8624–8636, 2010. [43] T. Obata, G. E. Brown, and M. B. Yaﬀe, “Map kinase pathways activated by stress: the p38 MAPK pathway,” Critical Care Medicine, vol. 28, no. 4, pp. N67–N77, 2000. [44] F. Wei, W. Guo, S. Zou, K. Ren, and R. Dubner, “Supraspinal glial-neuronal interactions contribute to descending pain facilitation,” Journal of Neuroscience, vol. 28, no. 42, pp. 10482– 10495, 2008. [45] J. J. Zhu, Y. Qin, M. Zhao, L. Van Aelst, and R. Malinow, “Ras and Rap control AMPA receptor traﬃcking during synaptic plasticity,” Cell, vol. 110, no. 4, pp. 443–455, 2002. [46] L. R. McMahon, L. R. Gerak, L. Carter, C. Ma, J. M. Cook, and C. P. France, “Plasticity in excitatory amino acid receptor- mediated descending pain modulation after inﬂammation,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 2, pp. 513–520, 2002. [47] Y. Guan, W. Guo, S.-P. Zou, R. Dubner, and K. Ren, “Inﬂammation-induced upregulation of AMPA receptor sub- unit expression in brain stem pain modulatory circuitry,” Pain, vol. 104, no. 1-2, pp. 401–413, 2003. [48] H. Imbe, S. Murakami, K. Okamoto, Y. Iwai-Liao, and E. Senba, “The eﬀects of acute and chronic restraint stress on activation of ERK in the rostral ventromedial medulla and locus coeruleus,” Pain, vol. 112, no. 3, pp. 361–371, 2004. [49] A. M. Magarin˜os and B. S. McEwen, “Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involve- ment of glucocorticoid secretion and excitatory amino acid receptors,” Neuroscience, vol. 69, no. 1, pp. 89–98, 1995. [50] Y. Kuroda and B. S. McEwen, “Eﬀect of chronic restraint stress and tianeptine on growth factors, growth-associated protein- 43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus,” Molecular Brain Research, vol. 59, no. 1, pp. 35–39, 1998. [51] A. Reine´s, M. Cereseto, A. Ferrero, C. Bonavita, and S. Wikin- ski, “Neuronal cytoskeletal alterations in an experimental model of depression,” Neuroscience, vol. 129, no. 3, pp. 529– 538, 2004. [52] E. Runde´n, P. O. Seglen, F.-M. Haug et al., “Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase- dependent mechanism,” Journal of Neuroscience, vol. 18, no. 18, pp. 7296–7305, 1998. [53] J. W. Haycock, N. G. Ahn, M. H. Cobb, and E. G. Krebs, “ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at